We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

177 hedge funds and large institutions have $592M invested in Meridian Bioscience Inc in 2018 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 60 increasing their positions, 62 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

684% more call options, than puts

Call options by funds: $1.31M | Put options by funds: $167K

13% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 16

0% more funds holding

Funds holding: 177 → 177 (0)

3% less repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 62

4% less capital invested

Capital invested by funds: $615M → $592M (-$22.8M)

Holders
177
Holders Change
–
Holders Change %
0%
% of All Funds
4.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
60
Reduced
62
Closed
16
Calls
$1.31M
Puts
$167K
Net Calls
+$1.14M
Net Calls Change
-$704K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$5.08M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$4.48M
3
Invesco
Invesco
Georgia
+$4.24M
4
Morgan Stanley
Morgan Stanley
New York
+$2.97M
5
Renaissance Technologies
Renaissance Technologies
New York
+$2.63M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$2.6M
2
Citadel Advisors
Citadel Advisors
Florida
-$2.2M
3
Prudential Financial
Prudential Financial
New Jersey
-$2.05M
4
Deutsche Bank
Deutsche Bank
Germany
-$1.93M
5
CS
Credit Suisse
Switzerland
-$1.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
First Trust Advisors
176
First Trust Advisors
Illinois
– -$764K -48,059 Closed
LCM
177
Laurion Capital Management
New York
– -$329K -20,698 Closed
AG
178
Advisor Group
Arizona
– -$273K -17,195 Closed
IAM
179
Integre Asset Management
New York
– -$204K -12,802 Closed
SG Americas Securities
180
SG Americas Securities
New York
– -$187K -11,742 Closed
IUHSA
181
Itau Unibanco Holding S.A.
Brazil
– -$162K -10,181 Closed
PIA
182
Piedmont Investment Advisors
North Carolina
– -$157K -9,853 Closed
Macquarie Group
183
Macquarie Group
Australia
– -$119K -7,476 Closed
GT
184
Glenmede Trust
Pennsylvania
– -$19K -1,200 Closed
QT
185
Quantbot Technologies
New York
– -$14K -900 Closed
RWP
186
RWA Wealth Partners
Massachusetts
– -$13K -844 Closed
CF
187
Centaurus Financial
California
– -$10K -600 Closed
Federated Hermes
188
Federated Hermes
Pennsylvania
– -$8K -489 Closed
Envestnet Asset Management
189
Envestnet Asset Management
Illinois
– -$4K -231 Closed
Carson Wealth (CWM LLC)
190
Carson Wealth (CWM LLC)
Nebraska
– -$3K -172 Closed
SEI Investments
191
SEI Investments
Pennsylvania
– -$2K -107 Closed
GWS
192
Glassman Wealth Services
Virginia
– -$47 -3 -15%
CAG
193
Csenge Advisory Group
Florida
– +$171 +11 New
4 5 6 7
8

VIVO Hedge Fund Activity: Q3 2018 in Review

177 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q3 2018, worth a combined $592M — down 3.7% from $615M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new VIVO positions and 16 closed out — a net gain of 2 holders — while 60 added to existing stakes and 62 trimmed.

The largest buyer was BlackRock, adding an estimated $5.08M. The largest seller was Millennium Management, cutting an estimated $2.6M.

  • 177 institutional investors held Meridian Bioscience Inc (VIVO) as of Q3 2018, unchanged from Q2 2018.
  • Funds reported $592M of Meridian Bioscience Inc stock for Q3 2018, down 3.7% quarter-over-quarter.
  • 18 funds opened new Meridian Bioscience Inc positions in Q3 2018 and 16 closed out, a net change of +2 holders.
  • The largest Meridian Bioscience Inc buyer in Q3 2018 was BlackRock, an estimated $5.08M added.
  • The largest Meridian Bioscience Inc seller in Q3 2018 was Millennium Management, an estimated $2.6M sold.

Based on aggregated 13F filings for Q3 2018.